Epoch Investment Partners, Inc. Halozyme Therapeutics, Inc. Transaction History
Epoch Investment Partners, Inc.
- $21.8 Billion
- Q1 2024
A detailed history of Epoch Investment Partners, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 1,433,612 shares of HALO stock, worth $73.9 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,433,612
Previous 1,163,033
23.26%
Holding current value
$73.9 Million
Previous $43 Million
35.67%
% of portfolio
0.27%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding HALO
# of Institutions
442Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$941 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$673 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$334 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$212 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$195 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.18B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...